The FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases) study is a significant milestone in the development of FLASH therapy
- FLASH therapy delivers radiation at ultra-high dose rates and may be over 100 times faster compared to conventional radiation therapy
- The study will use Varian's ProBeam® proton particle accelerator modified with a specialized module with FLASH capabilities
- Trial to evaluate patients with bone metastases, typically deep-seated tumors
PR Newswire
PALO ALTO, Calif., Oct. 12, 2020